Table of Contents
ascites
Pathogenesis
Management of transudative ascites
ascites
see also
gastroenterology
,
cirrhosis
Pathogenesis
usually transudative due to either:
elevated portal venous pressures
hypoalbuminaemia
enhanced renal retention of sodium
uncommonly, it is exudative as in:
spontaneous bacterial peritonitis (SBP)
neoplasia / cancer / tumours
such as:
hepatocellular carcinoma
peritoneal carcinomatosis
ovarian tumours
rarely,
mesenteric panniculitis (MP) / sclerosing mesenteritis
Management of transudative ascites
mild:
Rx underlying liver disease if possible
Rx precipitants such as infections
avoid salt in diet
avoid drugs that:
promote sodium retention (eg.
non-steroidal anti-inflammatory drugs (NSAIDs)
)
contain large amounts of sodium (eg. antacids,
aspirin (acetylsalicylic acid)
, effervescent preparations)
ensure adequate protein intake unless
hepatic encephalopathy
if symptomatic (eg. discomfort, distension):
spironolactone
50-100mg o mane
mod-severe ascites:
as for mild, plus,
consider admission to hospital for RIB, daily weighs, monitoring fluid balance, urine output, renal function.
send ascitic fluid to exclude
spontaneous bacterial peritonitis (SBP)
spironolactone
100mg o mane, increase dose by 100mg/day every 4-7 days prn to max. 400mg/d
if ascites prominent or refractory to above, add:
frusemide / furosemide / Lasix
40mg o mane
can use higher doses but may ppt hypokalaemia or aggravate renal impairment
if tense ascites or refractory, consider paracentesis over 1-3hrs to drain ascitic fluid:
if > 5L removed then infuse albumin 6-8g per L ascites removed
intractable acites:
requires specialised care with consideration of:
repeated paracentesis
reduction in portal pressure via:
operative portosystemic shunt
percutaneous insertion of shunt between hepatic & portal vein
transjugular intrahepatic portosystemic shunt (TIPS)
peritoneovenous shunt to drain ascites from peritoneum into SVC (Le Veen shunt)
liver transplantation